Atlas Venture Fund IX L.P. 13D/13G Filings for Surface Oncology, Inc. (SURF)

Atlas Venture Fund IX L.P. 13D and 13G filings for Surface Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-01-31
08:57 am
Unchanged		2022-12-3113GSurface Oncology, Inc.
SURF		Atlas Venture Fund IX L.P.2,945,453
4.870%		0
(Unchanged)		Filing
2022-01-25
11:30 am
Unchanged		2021-12-3113GSurface Oncology, Inc.
SURF		Atlas Venture Fund IX L.P.2,945,453
6.380%		0
(Unchanged)		Filing
2021-02-02
1:03 pm
Sale		2020-12-3113GSurface Oncology, Inc.
SURF		Atlas Venture Fund IX L.P.2,945,453
7.240%		-1,709,000decrease
(-36.72%)		Filing